Cargando…
Sialidase Activity in Human Blood Serum Has a Distinct Seasonal Pattern: A Pilot Study
Desialylation—loss of terminal sialic acid residues from glycoconjugates catalyzed by sialidases—is involved in many human diseases and is considered a key molecular event of atherosclerosis onset. Desialylated low-density lipoproteins with atherogenic properties have been detected in human blood pr...
Autores principales: | Glanz, Victor Y., Kashirskikh, Dmitry A., Grechko, Andrey V., Yet, Shaw-Fang, Sobenin, Igor A., Orekhov, Alexander N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463545/ https://www.ncbi.nlm.nih.gov/pubmed/32708035 http://dx.doi.org/10.3390/biology9080184 |
Ejemplares similares
-
Inhibition of sialidase activity as a therapeutic approach
por: Glanz, Victor Yu, et al.
Publicado: (2018) -
Changes in Mitochondrial Genome Associated with Predisposition to Atherosclerosis and Related Disease
por: Volobueva, Aleksandrina, et al.
Publicado: (2019) -
The Atherogenic Role of Circulating Modified Lipids in Atherosclerosis
por: Summerhill, Volha I., et al.
Publicado: (2019) -
Proatherogenic Sialidases and Desialylated Lipoproteins: 35 Years of Research and Current State from Bench to Bedside
por: Mezentsev, Alexandre, et al.
Publicado: (2021) -
Clinical Effectiveness of a Combination of Black Elder Berries, Violet Herb, and Calendula Flowers in Chronic Obstructive Pulmonary Disease: The Results of a Double-Blinded Placebo-Controlled Study
por: Kirichenko, Tatiana V., et al.
Publicado: (2020)